| Dr Ifueko Belinda Okundaye, MD | |
|
1540 Lyon Dr, Neenah, WI 54956-5069 | |
| (920) 727-4946 | |
| (920) 727-4956 |
| Full Name | Dr Ifueko Belinda Okundaye |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 37 Years |
| Location | 1540 Lyon Dr, Neenah, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467460410 | NPI | - | NPPES |
| 32229200 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 37832 (Wisconsin) | Secondary |
| 207R00000X | Internal Medicine | 37832 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St Michaels Hospital | Stevens point, WI | Hospital |
| Ascension Ne Wisconsin - St Elizabeth Campus | Appleton, WI | Hospital |
| Aspirus Wausau Hospital | Wausau, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ascension Medical Group-fox Valley Wisconsin Inc | 0244142420 | 258 |
| Aspirus Stevens Point Hospital And Clinics, Inc. | 1850358938 | 115 |
| Aspirus Wausau Hospital Inc | 6406757442 | 173 |
News Archive
Aeterna Zentaris Inc. today announced that Phase 1 trial results for its oral PI3K/Akt inhibitor, perifosine, showed the drug's activity against chemo-resistant and radio-resistant neuroblastoma, while allowing good quality of life and sparing vital organs. Neuroblastoma is a type of childhood cancer which usually begins in nerve tissues.
The initial findings of the ANRS CLEAC study coordinated by Pierre Frange (Hôpital Necker - AP-HP), help define the immunological and virological benefits of early antiretroviral therapy in HIV-infected children living in France.
Described as a hotspot of botanical diversity, there are more than 20,000 indigenous plant species in South Africa. Several thousand of them are used by traditional healers every day in that country for treating a range of problems from the common cold to serious diseases such as AIDS.
Multiple neuropsychiatric diseases are major predisposing factors for functional decline in older people and may play a greater role in this age-related phenomenon than cardiovascular diseases, according to a new study by researchers at Karolinska Institutet published in PLOS Medicine.
InnaVirVax, a biopharmaceutical company specialized in the research and development of therapeutic and diagnostic innovations focused on immune dysregulation, announced today that a new European patent application has been filed on VAC-3S, a "first-in-class" immunotherapy for the treatment of HIV infections.
› Verified 6 days ago
| Entity Name | The Monroe Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386720548 PECOS PAC ID: 3072425495 Enrollment ID: O20031104000392 |
News Archive
Aeterna Zentaris Inc. today announced that Phase 1 trial results for its oral PI3K/Akt inhibitor, perifosine, showed the drug's activity against chemo-resistant and radio-resistant neuroblastoma, while allowing good quality of life and sparing vital organs. Neuroblastoma is a type of childhood cancer which usually begins in nerve tissues.
The initial findings of the ANRS CLEAC study coordinated by Pierre Frange (Hôpital Necker - AP-HP), help define the immunological and virological benefits of early antiretroviral therapy in HIV-infected children living in France.
Described as a hotspot of botanical diversity, there are more than 20,000 indigenous plant species in South Africa. Several thousand of them are used by traditional healers every day in that country for treating a range of problems from the common cold to serious diseases such as AIDS.
Multiple neuropsychiatric diseases are major predisposing factors for functional decline in older people and may play a greater role in this age-related phenomenon than cardiovascular diseases, according to a new study by researchers at Karolinska Institutet published in PLOS Medicine.
InnaVirVax, a biopharmaceutical company specialized in the research and development of therapeutic and diagnostic innovations focused on immune dysregulation, announced today that a new European patent application has been filed on VAC-3S, a "first-in-class" immunotherapy for the treatment of HIV infections.
› Verified 6 days ago
| Entity Name | Ascension Medical Group-fox Valley Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730126392 PECOS PAC ID: 0244142420 Enrollment ID: O20031105000351 |
News Archive
Aeterna Zentaris Inc. today announced that Phase 1 trial results for its oral PI3K/Akt inhibitor, perifosine, showed the drug's activity against chemo-resistant and radio-resistant neuroblastoma, while allowing good quality of life and sparing vital organs. Neuroblastoma is a type of childhood cancer which usually begins in nerve tissues.
The initial findings of the ANRS CLEAC study coordinated by Pierre Frange (Hôpital Necker - AP-HP), help define the immunological and virological benefits of early antiretroviral therapy in HIV-infected children living in France.
Described as a hotspot of botanical diversity, there are more than 20,000 indigenous plant species in South Africa. Several thousand of them are used by traditional healers every day in that country for treating a range of problems from the common cold to serious diseases such as AIDS.
Multiple neuropsychiatric diseases are major predisposing factors for functional decline in older people and may play a greater role in this age-related phenomenon than cardiovascular diseases, according to a new study by researchers at Karolinska Institutet published in PLOS Medicine.
InnaVirVax, a biopharmaceutical company specialized in the research and development of therapeutic and diagnostic innovations focused on immune dysregulation, announced today that a new European patent application has been filed on VAC-3S, a "first-in-class" immunotherapy for the treatment of HIV infections.
› Verified 6 days ago
| Entity Name | Thedacare Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376656959 PECOS PAC ID: 1759294887 Enrollment ID: O20031106000088 |
News Archive
Aeterna Zentaris Inc. today announced that Phase 1 trial results for its oral PI3K/Akt inhibitor, perifosine, showed the drug's activity against chemo-resistant and radio-resistant neuroblastoma, while allowing good quality of life and sparing vital organs. Neuroblastoma is a type of childhood cancer which usually begins in nerve tissues.
The initial findings of the ANRS CLEAC study coordinated by Pierre Frange (Hôpital Necker - AP-HP), help define the immunological and virological benefits of early antiretroviral therapy in HIV-infected children living in France.
Described as a hotspot of botanical diversity, there are more than 20,000 indigenous plant species in South Africa. Several thousand of them are used by traditional healers every day in that country for treating a range of problems from the common cold to serious diseases such as AIDS.
Multiple neuropsychiatric diseases are major predisposing factors for functional decline in older people and may play a greater role in this age-related phenomenon than cardiovascular diseases, according to a new study by researchers at Karolinska Institutet published in PLOS Medicine.
InnaVirVax, a biopharmaceutical company specialized in the research and development of therapeutic and diagnostic innovations focused on immune dysregulation, announced today that a new European patent application has been filed on VAC-3S, a "first-in-class" immunotherapy for the treatment of HIV infections.
› Verified 6 days ago
| Entity Name | Aspirus Rhinelander & Tomahawk Hospitals & Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144991340 PECOS PAC ID: 9335059856 Enrollment ID: O20031126000706 |
News Archive
Aeterna Zentaris Inc. today announced that Phase 1 trial results for its oral PI3K/Akt inhibitor, perifosine, showed the drug's activity against chemo-resistant and radio-resistant neuroblastoma, while allowing good quality of life and sparing vital organs. Neuroblastoma is a type of childhood cancer which usually begins in nerve tissues.
The initial findings of the ANRS CLEAC study coordinated by Pierre Frange (Hôpital Necker - AP-HP), help define the immunological and virological benefits of early antiretroviral therapy in HIV-infected children living in France.
Described as a hotspot of botanical diversity, there are more than 20,000 indigenous plant species in South Africa. Several thousand of them are used by traditional healers every day in that country for treating a range of problems from the common cold to serious diseases such as AIDS.
Multiple neuropsychiatric diseases are major predisposing factors for functional decline in older people and may play a greater role in this age-related phenomenon than cardiovascular diseases, according to a new study by researchers at Karolinska Institutet published in PLOS Medicine.
InnaVirVax, a biopharmaceutical company specialized in the research and development of therapeutic and diagnostic innovations focused on immune dysregulation, announced today that a new European patent application has been filed on VAC-3S, a "first-in-class" immunotherapy for the treatment of HIV infections.
› Verified 6 days ago
| Entity Name | Aspirus Wausau Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922321140 PECOS PAC ID: 6406757442 Enrollment ID: O20040114000297 |
News Archive
Aeterna Zentaris Inc. today announced that Phase 1 trial results for its oral PI3K/Akt inhibitor, perifosine, showed the drug's activity against chemo-resistant and radio-resistant neuroblastoma, while allowing good quality of life and sparing vital organs. Neuroblastoma is a type of childhood cancer which usually begins in nerve tissues.
The initial findings of the ANRS CLEAC study coordinated by Pierre Frange (Hôpital Necker - AP-HP), help define the immunological and virological benefits of early antiretroviral therapy in HIV-infected children living in France.
Described as a hotspot of botanical diversity, there are more than 20,000 indigenous plant species in South Africa. Several thousand of them are used by traditional healers every day in that country for treating a range of problems from the common cold to serious diseases such as AIDS.
Multiple neuropsychiatric diseases are major predisposing factors for functional decline in older people and may play a greater role in this age-related phenomenon than cardiovascular diseases, according to a new study by researchers at Karolinska Institutet published in PLOS Medicine.
InnaVirVax, a biopharmaceutical company specialized in the research and development of therapeutic and diagnostic innovations focused on immune dysregulation, announced today that a new European patent application has been filed on VAC-3S, a "first-in-class" immunotherapy for the treatment of HIV infections.
› Verified 6 days ago
| Entity Name | Howard Young Medical Center Inc Of Woodruff Wisconsin |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184673352 PECOS PAC ID: 4183519606 Enrollment ID: O20040419000970 |
News Archive
Aeterna Zentaris Inc. today announced that Phase 1 trial results for its oral PI3K/Akt inhibitor, perifosine, showed the drug's activity against chemo-resistant and radio-resistant neuroblastoma, while allowing good quality of life and sparing vital organs. Neuroblastoma is a type of childhood cancer which usually begins in nerve tissues.
The initial findings of the ANRS CLEAC study coordinated by Pierre Frange (Hôpital Necker - AP-HP), help define the immunological and virological benefits of early antiretroviral therapy in HIV-infected children living in France.
Described as a hotspot of botanical diversity, there are more than 20,000 indigenous plant species in South Africa. Several thousand of them are used by traditional healers every day in that country for treating a range of problems from the common cold to serious diseases such as AIDS.
Multiple neuropsychiatric diseases are major predisposing factors for functional decline in older people and may play a greater role in this age-related phenomenon than cardiovascular diseases, according to a new study by researchers at Karolinska Institutet published in PLOS Medicine.
InnaVirVax, a biopharmaceutical company specialized in the research and development of therapeutic and diagnostic innovations focused on immune dysregulation, announced today that a new European patent application has been filed on VAC-3S, a "first-in-class" immunotherapy for the treatment of HIV infections.
› Verified 6 days ago
| Entity Name | Premier Health Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275549594 PECOS PAC ID: 6709869266 Enrollment ID: O20040608000356 |
News Archive
Aeterna Zentaris Inc. today announced that Phase 1 trial results for its oral PI3K/Akt inhibitor, perifosine, showed the drug's activity against chemo-resistant and radio-resistant neuroblastoma, while allowing good quality of life and sparing vital organs. Neuroblastoma is a type of childhood cancer which usually begins in nerve tissues.
The initial findings of the ANRS CLEAC study coordinated by Pierre Frange (Hôpital Necker - AP-HP), help define the immunological and virological benefits of early antiretroviral therapy in HIV-infected children living in France.
Described as a hotspot of botanical diversity, there are more than 20,000 indigenous plant species in South Africa. Several thousand of them are used by traditional healers every day in that country for treating a range of problems from the common cold to serious diseases such as AIDS.
Multiple neuropsychiatric diseases are major predisposing factors for functional decline in older people and may play a greater role in this age-related phenomenon than cardiovascular diseases, according to a new study by researchers at Karolinska Institutet published in PLOS Medicine.
InnaVirVax, a biopharmaceutical company specialized in the research and development of therapeutic and diagnostic innovations focused on immune dysregulation, announced today that a new European patent application has been filed on VAC-3S, a "first-in-class" immunotherapy for the treatment of HIV infections.
› Verified 6 days ago
| Entity Name | Aspirus Stevens Point Hospital & Clinics, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538112230 PECOS PAC ID: 1850358938 Enrollment ID: O20041210000558 |
News Archive
Aeterna Zentaris Inc. today announced that Phase 1 trial results for its oral PI3K/Akt inhibitor, perifosine, showed the drug's activity against chemo-resistant and radio-resistant neuroblastoma, while allowing good quality of life and sparing vital organs. Neuroblastoma is a type of childhood cancer which usually begins in nerve tissues.
The initial findings of the ANRS CLEAC study coordinated by Pierre Frange (Hôpital Necker - AP-HP), help define the immunological and virological benefits of early antiretroviral therapy in HIV-infected children living in France.
Described as a hotspot of botanical diversity, there are more than 20,000 indigenous plant species in South Africa. Several thousand of them are used by traditional healers every day in that country for treating a range of problems from the common cold to serious diseases such as AIDS.
Multiple neuropsychiatric diseases are major predisposing factors for functional decline in older people and may play a greater role in this age-related phenomenon than cardiovascular diseases, according to a new study by researchers at Karolinska Institutet published in PLOS Medicine.
InnaVirVax, a biopharmaceutical company specialized in the research and development of therapeutic and diagnostic innovations focused on immune dysregulation, announced today that a new European patent application has been filed on VAC-3S, a "first-in-class" immunotherapy for the treatment of HIV infections.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ifueko Belinda Okundaye, MD 1540 Lyon Dr, Neenah, WI 54956-5069 Ph: (920) 727-4946 | Dr Ifueko Belinda Okundaye, MD 1540 Lyon Dr, Neenah, WI 54956-5069 Ph: (920) 727-4946 |
News Archive
Aeterna Zentaris Inc. today announced that Phase 1 trial results for its oral PI3K/Akt inhibitor, perifosine, showed the drug's activity against chemo-resistant and radio-resistant neuroblastoma, while allowing good quality of life and sparing vital organs. Neuroblastoma is a type of childhood cancer which usually begins in nerve tissues.
The initial findings of the ANRS CLEAC study coordinated by Pierre Frange (Hôpital Necker - AP-HP), help define the immunological and virological benefits of early antiretroviral therapy in HIV-infected children living in France.
Described as a hotspot of botanical diversity, there are more than 20,000 indigenous plant species in South Africa. Several thousand of them are used by traditional healers every day in that country for treating a range of problems from the common cold to serious diseases such as AIDS.
Multiple neuropsychiatric diseases are major predisposing factors for functional decline in older people and may play a greater role in this age-related phenomenon than cardiovascular diseases, according to a new study by researchers at Karolinska Institutet published in PLOS Medicine.
InnaVirVax, a biopharmaceutical company specialized in the research and development of therapeutic and diagnostic innovations focused on immune dysregulation, announced today that a new European patent application has been filed on VAC-3S, a "first-in-class" immunotherapy for the treatment of HIV infections.
› Verified 6 days ago
Kelsey Kienert, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Main St, Neenah, WI 54956 Phone: 920-720-1463 | |
Dr. Benjamin J Duffy, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Theda Clark Medical Plz Ste 420, Neenah, WI 54956 Phone: 920-720-7211 | |
William L Nelson, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 101 Main St, Neenah, WI 54956 Phone: 920-727-4220 | |
Dr. Barbara L Lauderdale, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 804 E Forest Ave, Neenah, WI 54956 Phone: 920-722-6692 | |
Taylor B Doberstein, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Theda Clark Medical Plz Ste 240, Neenah, WI 54956 Phone: 920-831-5050 Fax: 920-727-4511 | |
James R Burns, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Main St, Neenah, WI 54956 Phone: 920-727-4220 | |
Kim R Riess-sagers, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 N Commercial St, Suite 200, Neenah, WI 54956 Phone: 920-886-0818 Fax: 920-886-0773 |